Executive Director Pharmacometrics
Luzsana Biotechnonology (subsidiary of Jiangsu Hengrui Pharmaceuticals Co., Ltd), Switzerland
Nassim Djebli, PharmD - PhD
Executive Director Pharmacometrics - Luzsana Biotechnology (subsidiary of Hengrui Pharmaceuticals)
Nassim Djebli has 15+ years of pharmaceutical industry experience (Sanofi, Hoffmann-La Roche and now at Luzsana/Hengrui). He is currently the Executive Director (Pharmacometrics Head) at Luzsana/Hengrui. Before joining Luzsana/Hengrui, Nassim Djebli was Senior Principal Clinical Pharmacometrician at Hoffmann-La Roche where he was involved as the Pharmacometrics Lead for key late stage Oncology projects including NDA and BLA submissions. He was involved in defining the strategy to support model-informed decision-making in clinical drug development in Oncology, in collaboration with the Clinical Pharmacology and Project Team. In parallel, he was managing the Pharmacometrics Oncology portfolio, was a People Coach and the Oncology Hub coordinator within the Predictive Modeling and Data Analytics Department. Before that, Nassim worked at Sanofi Pharmaceutical, as Senior Pharmacometrician.
Nassim has a strong knowledge in Pharmacometrics tools with a focus on PopPK/PD and PBPK/PD with a background in Pharmacogenetics, cell culture, in vitro methods and drug metabolism.
Nassim Djebli received his Doctor of Pharmacy (PharmD) and a Master’s Degree at the Université of Nancy in Clinical Pharmacology and a PhD in Pharmacometrics and Pharmacogenetics of immunosuppressive drugs from the University Hospital of Limoges in France.